Beat Joint Pain The Options Library
Educational information only. No diagnosis, treatment recommendation, personalized dose, or emergency service.

HomePrescriptionMethotrexate

Independent source profile

Methotrexate

Methotrexate is a prescription disease-modifying antirheumatic drug used for diagnosed conditions such as rheumatoid arthritis and certain other inflammatory diseases. It is not a general pain medicine for unexplained joint pain.

ClassificationPrescription conventional DMARD
PurposeDisease-modifying therapy for diagnosed inflammatory conditions
Last source checkAugust 3, 2026
Editorial statusIndependent • Not sponsored

Product identity

What it is

Active ingredient or category: Methotrexate

Regulatory classification: Prescription conventional DMARD

What official sources say

  • NIAMS separates disease-modifying therapy from medicines used only for symptom relief in rheumatoid arthritis.
  • The MedlinePlus drug page provides the consumer medication guide, precautions, monitoring context, and serious warnings.
Safety signal—not a complete warning list: Methotrexate has serious warnings and requires condition-specific prescribing and monitoring. This page does not provide a dose or schedule; medication errors can be dangerous. Always read the current label or source for the exact product.

Questions to take to a clinician or pharmacist

  1. What underlying condition is this intended to modify?
  2. What monitoring and follow-up does the prescriber require?
  3. Which medicines, supplements, vaccines, pregnancy plans, or alcohol use should be discussed?

Sources reviewed

Links open the authoritative source. Product labels and guidance can change; verify the current version before relying on any summary.

Review status: This page received an editorial source check on August 3, 2026. No clinician or pharmacist is credited as independently reviewing it. Report a correction.

More in Prescription

Prescription

Prescription NSAIDs

Prescription nonsteroidal anti-inflammatory drugs are used in several joint-related conditions to address pain and inflammation. They do not all have the same dosing, interactions, or risk profile, and they are not disease-modifying therapy for inflammatory arthritis.

Read source profile
Prescription

TNF inhibitors

Tumor necrosis factor inhibitors are biologic medicines used in selected diagnosed inflammatory diseases. They are not stronger versions of an ordinary pain reliever and are prescribed within a condition-specific plan.

Read source profile
Prescription

JAK inhibitors

Janus kinase inhibitors are targeted prescription medicines used for certain inflammatory conditions. Their place in treatment, approved uses, and warnings are product-specific and require professional evaluation.

Read source profile